🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/09/2013 | 44,97 | 45,69 | 44,95 | 45,50 | +1,00% | 1,63% | 11.596.330 |
| 03/09/2013 | 45,34 | 45,48 | 44,86 | 45,05 | -0,17% | 1,37% | 14.894.595 |
| 30/08/2013 | 44,93 | 45,31 | 44,87 | 45,12 | +0,40% | 0,98% | 8.725.962 |
| 29/08/2013 | 44,82 | 45,23 | 44,65 | 44,94 | +0,02% | 1,30% | 10.160.779 |
| 28/08/2013 | 44,64 | 45,23 | 44,34 | 44,93 | -0,04% | 1,99% | 10.283.186 |
| 27/08/2013 | 45,15 | 45,34 | 44,78 | 44,95 | -1,07% | 1,25% | 11.362.835 |
| 26/08/2013 | 45,61 | 45,71 | 45,35 | 45,44 | -0,23% | 0,77% | 9.662.770 |
| 23/08/2013 | 45,78 | 45,78 | 45,28 | 45,54 | -0,17% | 1,10% | 9.616.762 |
| 22/08/2013 | 45,45 | 45,78 | 45,23 | 45,62 | +0,74% | 1,22% | 9.044.554 |
| 21/08/2013 | 45,38 | 45,84 | 45,13 | 45,29 | -0,21% | 1,56% | 11.318.400 |
| 20/08/2013 | 45,47 | 46,16 | 45,38 | 45,38 | -0,04% | 1,72% | 14.771.560 |
| 19/08/2013 | 45,30 | 45,61 | 45,28 | 45,40 | -0,25% | 0,74% | 8.780.458 |
| 16/08/2013 | 45,60 | 45,80 | 45,31 | 45,52 | -0,56% | 1,09% | 13.834.019 |
| 15/08/2013 | 46,07 | 46,15 | 45,66 | 45,77 | -1,24% | 1,06% | 11.885.892 |
| 14/08/2013 | 46,33 | 46,53 | 46,19 | 46,35 | +0,29% | 0,72% | 8.940.383 |
| 13/08/2013 | 46,30 | 46,61 | 45,88 | 46,21 | -0,08% | 1,59% | 7.812.945 |
| 12/08/2013 | 45,95 | 46,57 | 45,89 | 46,25 | +0,17% | 1,49% | 10.411.985 |
| 09/08/2013 | 46,22 | 46,55 | 46,05 | 46,17 | -0,16% | 1,07% | 8.266.834 |
| 08/08/2013 | 46,43 | 46,60 | 45,98 | 46,25 | -0,16% | 1,34% | 9.045.707 |
| 07/08/2013 | 46,14 | 46,52 | 46,14 | 46,33 | +0,23% | 0,83% | 10.130.282 |
| 06/08/2013 | 46,26 | 46,36 | 45,89 | 46,22 | -0,19% | 1,03% | 10.421.836 |
| 05/08/2013 | 46,17 | 46,43 | 45,87 | 46,31 | -0,02% | 1,22% | 7.114.977 |
| 02/08/2013 | 46,22 | 46,32 | 45,97 | 46,32 | -0,08% | 0,74% | 9.350.466 |
| 01/08/2013 | 46,22 | 46,45 | 45,84 | 46,36 | +0,85% | 1,32% | 14.198.094 |
| 31/07/2013 | 46,28 | 46,50 | 45,77 | 45,96 | +0,25% | 1,57% | 22.612.067 |
| 30/07/2013 | 46,08 | 46,83 | 45,65 | 45,85 | -0,60% | 2,57% | 17.583.554 |
| 29/07/2013 | 46,06 | 46,56 | 45,94 | 46,13 | -0,31% | 1,33% | 10.785.597 |
| 26/07/2013 | 45,85 | 46,27 | 45,59 | 46,27 | +0,66% | 1,48% | 10.318.818 |
| 25/07/2013 | 45,35 | 45,98 | 45,18 | 45,96 | +0,84% | 1,77% | 10.522.339 |
| 24/07/2013 | 45,73 | 45,84 | 45,33 | 45,58 | -0,33% | 1,11% | 9.370.378 |